Literature DB >> 23253218

The role of narrow-band imaging in the management of non-muscle-invasive bladder cancer.

Angelo Naselli1, Rodolfo Hurle, Paolo Puppo.   

Abstract

Narrow-band imaging is a young optical enhancement technology for endoscopy. It is a filter to the standard white light which increases the contrast between underlying vasculature and epithelial strata of the mucosa, improving the detection of bladder cancer with particular regard to high grade, flat lesions. Narrow band imaging is absolutely safe, may be used any time during a procedure, either during office cystosopy or transurethral resection, and implies a minimal burden for the healthcare provider given the absence of a learning curve and the limited cost of the camera and light source. The ameliorated detection translates into an improved management of the disease and a lower recurrence risk in prospective randomized studies, suggesting the inclusion of the technology in daily clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 23253218     DOI: 10.1586/era.12.137

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  4 in total

1.  Urovision 2020: The future of urology.

Authors:  Vivek Venkatramani
Journal:  Indian J Urol       Date:  2015 Apr-Jun

2.  A comparison of NBI and WLI cystoscopy in detecting non-muscle-invasive bladder cancer: A prospective, randomized and multi-center study.

Authors:  Zhangqun Ye; Jia Hu; Xiaodong Song; Fan Li; Xuetao Zhao; Shan Chen; Xiaofeng Wang; Dalin He; Jinhai Fan; Dingwei Ye; Jinchun Xing; Tiejun Pan; Dongwen Wang
Journal:  Sci Rep       Date:  2015-06-05       Impact factor: 4.379

Review 3.  Role of Macroscopic Image Enhancement in Diagnosis of Non-Muscle-Invasive Bladder Cancer: An Analytical Review.

Authors:  Prashant Motiram Mulawkar; Gyanendra Sharma; Ashwin Tamhankar; Utsav Shah; Rickaz Raheem
Journal:  Front Surg       Date:  2022-02-21

4.  Novel Visualization Methods Assisted Transurethral Resection for Bladder Cancer: An Updated Survival-Based Systematic Review and Meta-Analysis.

Authors:  Honglin Li; Yubin Cao; Pingchuan Ma; Zhongkai Ma; Chunjie Li; Wenbin Yang; Lingyun Zhou
Journal:  Front Oncol       Date:  2021-07-13       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.